Peter Loftus
Appearances
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Novo Nordisk, yesterday, the stock had the best session in about two and a half years.
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Right. All right, have you heard of this so-called miracle drug Ozempic?
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.